Predicting mortality in people with Type 2 diabetes mellitus after major complications: A study using Swedish National Diabetes Register data

Diabetic Medicine

Volumn 31, Issue 8, 2014, Pages 954-962

  Kelly, P J ^a   Clarke, P M ^b   Hayes, A J ^a   Gerdtham, U G ^c   Cederholm, J ^d   Nilsson, P ^c   Eliasson, B ^e   Gudbjornsdottir, S ^e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LUND UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPUTATION; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; KIDNEY FAILURE; LIFE EXPECTANCY; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; ADVERSE EFFECTS; AGED; BIOLOGICAL MODEL; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; FOLLOW UP; PROGNOSIS; PROSPECTIVE STUDY; SWEDEN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMPUTATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; LIFE EXPECTANCY; MALE; MODELS, BIOLOGICAL; MORTALITY; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RENAL INSUFFICIENCY; RISK FACTORS; STROKE; SWEDEN;

EID: 84904327289     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12468     Document Type: Article

References (26)

1. DECODE study group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 1999; 354: 617-621.
2. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA. Mortality in people with type 2 diabetes in the UK. Diabet Med 2006; 23: 516-521.
3. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011; 364: 829-841.
4. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-2222.
5. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction. Circulation 2000; 102: 1014-1019.
6. Abbud ZA, Shindler DM, Wilson AC, Kostis JB. Myocardial infarction data acquisition system study sroup, effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study. Am Heart J 1995; 130: 51-58.
7. Miettinen H, Lehto S, Salomaa V, Mähönen M, Niemelä M, Haffner SM et al. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care 1998; 21: 69-75.
8. Mankovsky BN, Ziegler D. Stroke in patients with diabetes mellitus. Diabetes Metab Res Rev 2004; 20: 268-287.
9. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of Diabetes Mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 2007; 157: 1145-1151.
10. Manuel DG, Schultz S. Health-Related Quality of Life and Health-Adjusted Life Expectancy of People With Diabetes in Ontario, Canada, 1996-1997. Diabetes Care 2004; 27: 407-414.
11. Wright JC, Weinstein MC. Gains in Life Expectancy from Medical Interventions - Standardizing Data on Outcomes. N Engl J Med 1998; 339: 380-386.
12. Hayes AJ, Leal J, Kelman CW, Clarke PM. Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia. Diabet Med 2011; 28: 428-435.
13. Leal J, Gray AM, Clarke PM. Development of life-expectancy tables for people with type 2 diabetes. Eur Heart J 2009; 30: 834-839.
14. Price HC, Clarke PM, Gray AM, Holman RR. Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities. Med Decis Making 2010; 30: 409-414.
15. Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Nunez L, Gudbjörnsdóttir S et al. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13, 087 patients. Diabetologia 2009; 52: 65-73.
16. Eliasson B, Cederholm J, Nilsson P, Gudbjörnsdóttir S. The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003. Diabet Med 2005; 22: 1420-1426.
17. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004; 50: 166-174.
18. Olshansky SJ, Carnes BA. Ever since Gompertz. Demography 1997; 34: 1-15.
19. Nelson CL, Sun JL, Tsiatis AA, Mark DB. Empirical estimation of life expectancy from large clinical trials: Use of left-truncated, right-censored survival analysis methodology. Stat Med 2008; 27: 5525-5555.
20. Little RJ, Rubin DB. Statistical Analysis With Missing Data, 2nd ed. Hoboken (NJ): Wiley-InterScience, 2002.
21. Carlin JB, Galati JC, Royston P. A new framework for managing and analyzing multiple imputed data in Stata. Stata Journal 2008; 8: 49-67.
22. Hayes AJ, Leal J, Gray AM, Holman RR, Clarke PM. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia 2013; 56: 1925-1933.
23. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L et al. Systolic blood pressure at admission, clinicalcharacteristics, and outcomes in patientshospitalized with acuteheart failure. JAMA 2006; 296: 2217-2226.
24. Molander L, Lövheim H, Norman T, Nordström P, Gustafson Y. Lower systolic blood pressure is associated with greater mortality in people aged 85 and older. Am Geriatr Soc 2008; 56: 1853-1859.
25. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care 2004; 27: 201-207.
26. American Diabetes Association Consensus Panel. Guidelines for Computer Modeling of Diabetes and its Complications. Diabetes Care 2004; 27: 2262-2265.